Vascular Sealant Market Report 2026

Vascular Sealant Market Overview

• Vascular Sealant market size has reached to $1.71 billion in 2025 • Expected to grow to $2.51 billion in 2030 at a compound annual growth rate (CAGR) of 8% • Growth Driver: Surge In Cardiovascular Disease Fueling The Growth Of The Market Due To Rising Global Disease Burden • Market Trend: Innovative Closure Device Enhances Patient Recovery And Procedure Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Vascular Sealant Market?

A vascular sealant is a medical adhesive designed to achieve hemostasis by sealing blood vessels and preventing bleeding. It typically consists of synthetic or biologically derived materials that form a stable barrier upon contact with blood or tissue. These sealants support tissue repair and reduce the risk of hemorrhage during surgical procedures. The main product types of vascular sealant include fibrin sealants, collagen based sealants, synthetic sealants, and other product types. Fibrin sealants refer to biologically derived adhesives that mimic the natural clotting process to achieve hemostasis and tissue sealing during surgical procedures. These products are developed using material types such as natural biological materials, synthetic polymeric materials, and semi synthetic materials, and are available in form factors including liquid, patch, spray or foam, and pre filled applicator kits. They find application in cardiovascular surgery, general surgery, neurosurgery, orthopedic surgery, and other applications, serving end users including hospitals, ambulatory surgical centers, specialty clinics, and other end users.

What Is The Vascular Sealant Market Growth Forecast?

The vascular sealant market size is expected to see strong growth in the next few years.It will grow to $2.51 billion by 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increasing adoption of minimally invasive surgeries, rising demand for advanced biomaterials, growing investment in surgical innovation, expansion of outpatient surgical centers, increasing focus on patient safety and faster recovery.Major trends in the forecast period include increasing adoption of advanced hemostatic agents in surgeries, rising preference for minimally invasive surgical sealants, growing demand for fast-acting and high-strength vascular sealants, development of bioresorbable and biocompatible sealant materials, expansion of multi-application sealants across surgical specialties.

Global Vascular Sealant Market Segmentation

1) By Product Type: Fibrin Sealants, Collagen Based Sealants, Synthetic Sealants, Other Product Types 2) By Material Type: Natural Biological Materials, Synthetic Polymeric Materials, Semi Synthetic Materials 3) By Form Factor: Liquid, Patch, Spray Or Foam, Pre Filled Applicator Kits 4) By Application: Cardiovascular Surgery, General Surgery, Neurosurgery, Orthopedic Surgery, Other Applications 5) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End Users Subsegments: 1) By Fibrin Sealants: Human Plasma Derived Sealants, Bovine Plasma Derived Sealants, Recombinant Fibrin Sealants, Combination Fibrin Sealants 2) By Collagen Based Sealants: Bovine Collagen Sealants, Porcine Collagen Sealants, Equine Collagen Sealants, Crosslinked Collagen Sealants 3) By Synthetic Sealants: Polyethylene Glycol Sealants, Cyanoacrylate Sealants, Albumin Based Sealants, Gelatin Based Sealants 4) By Other Product Types: Combination Sealants, Hydrogel Sealants, Polysaccharide Based Sealants, Enzymatic Sealants

What Is The Driver Of The Vascular Sealant Market?

The growing cardiovascular disease is expected to propel the growth of the vascular sealant industry going forward.Cardiovascular disease refers to a group of disorders affecting the heart and blood vessels, including conditions such as ischemic heart disease and stroke.Cardiovascular diseases are growing due to population aging and growth, as well as increased exposure to risk factors such as obesity, diabetes, high blood pressure, poor diet, sedentary lifestyle, and smoking, which collectively raise the likelihood of heart and blood vessel disorders.Vascular sealants help address cardiovascular disease by enabling effective bleeding control, supporting vascular repair, and reducing complications during surgical procedures.For instance, according to the Scottish Health Survey 2024 by the Scottish Government, a Scotland-based government administration, 16% of adults reported living with any cardiovascular disease (CVD), with prevalence rising from 4% among those aged 16–24 to 42% among adults aged 75 and over.Therefore, the rising prevalence of cardiovascular disease is driving the growth of the vascular sealant industry.

Key Players In The Global Vascular Sealant Market

Major companies operating in the vascular sealant market are Johnson & Johnson, Pfizer Inc., Medtronic plc, Stryker Corporation, Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Grifols S. A., Terumo Corporation, Teleflex Incorporated, Integra LifeSciences Holdings Corporation, CSL Behring LLC, Advanced Medical Solutions Group plc, SkinStitch Inc., Tricol Biomedical Inc., Cellphire Therapeutics Inc., Artivion Inc., GluStitch Inc., CuraMedical B. V., Endomedix Inc.

Global Vascular Sealant Market Trends and Insights

Major companies operating in the vascular sealant market are focusing on leveraging innovative technologies such as grip technology to achieve faster hemostasis and improved patient recovery. Grip technology, a hydrophilic polymer-based system, forms a secure and flexible seal at the vascular access site, helping achieve rapid hemostasis, minimizing the risk of bleeding complications, reducing patient recovery time, and enabling earlier ambulation and discharge, while providing a minimally invasive alternative to traditional manual compression methods. For instance, in July 2024, Cordis Corporation, a US-based medical device company, received U. S. Food and Drug Administration (FDA) approval for the Mynx Control Venous VCD, an innovative device that leverages Grip Technology based on hydrophilic, bioinert polyethylene glycol. The Mynx Control Venous VCD provides effective closure for midbore venous puncture sites, including those used in electrophysiology procedures, and demonstrated 100% procedural and device success in clinical trials. Key benefits include significantly reduced time to hemostasis (2. 1 minutes vs 11. 4 minutes for manual compression), faster ambulation, and earlier discharge eligibility, enhancing both patient experience and facility efficiency.

What Are Latest Mergers And Acquisitions In The Vascular Sealant Market?

In January 2026, Haemonetics Corporation, a US-based medical technology company, acquired Vivasure Medical Limited for an undisclosed amount. With this acquisition, Haemonetics aims to expand its portfolio of large-bore vascular closure devices, enhance its technological capabilities in minimally invasive vascular procedures, accelerate innovation in structural heart and endovascular treatments, and broaden its global customer base in interventional cardiology and vascular surgery. Vivasure Medical Limited is an ireland-based medical technology company that specializes in developing vascular sealant.

Regional Insights

North America was the largest region in the vascular sealant market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Vascular Sealant Market?

The vascular sealant market consists of sales of polyethylene glycol sealants, cyanoacrylate adhesives, albumin-based sealants, collagen-based hemostatic sealants, thrombin-based sealants, gelatin-based sealants, bioabsorbable vascular sealants, hemostatic patches, surgical sealant applicators, dual syringe delivery systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

What is the Market Assessment and Strategic Outlook for the Vascular Sealant Industry?

The vascular sealant market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the vascular sealant industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

What is the Market Assessment and Strategic Outlook for the Vascular Sealant Market Report 2026?

The vascular sealant market research report is one of a series of new reports from The Business Research Company that provides vascular sealant market statistics, including vascular sealant industry global market size, regional shares, competitors with a vascular sealant market share, detailed vascular sealant market segments, market trends and opportunities, and any further data you may need to thrive in the vascular sealant industry. This vascular sealant market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.